Canaccord Genuity’s $282 target on ABBV

ABBV AbbVie

$253 → $282 (+11%) by Jul 2027

raises · said Jul 22, 2026 · 12-month default horizon

Open: judged on the close on Jul 22, 2027

The article this target came from

Canaccord raises Abbvie stock price target to $282 on growth outlook

Investing.com · Jul 22, 2026

Canaccord raises Abbvie stock price target to $282 on growth outlook

Canaccord Genuity’s track record → AbbVie →

A fact about what Canaccord Genuity published, as reported by Investing.com, not a recommendation from Dalsna Finance; Canaccord Genuity is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.